Answers are grounded in this paper and cite their sources.
A new mononuclear Ni(II) complex [NiL] (1) of an unsymmetrically dicondensed N₂O₃ donor ligand, H₂L ( N-α-methylsalicylidene- N'-3-methoxysalicylidene-1,3-propanediamine), has been synthesized. Complex 1 on reaction with Mn(ClO₄)₂·6H₂O and NaN₃ in different molar ratios yielded three novel heterometallic NiII-MnII complexes, [(NiL)₂Mn(N₃)](ClO₄) (2), [(NiL)₂Mn₂(N₃)₂(μ₁,₁-N₃)₂(CH₃OH)₂] (3), and [{(NiL)₂Mn}₂(μ₁,₃-N₃)(H₂O)]·(CH₃OH),(ClO₄)₃ (4). The single crystal structure analyses show a trinuclear NiII₂MnII structure for complex 2 and a tetranuclear NiII₂MnII₂ structure where two dinuclear NiIIMnII units are connected via μ₁,₁-azido and phenoxido bridges for complex 3. Complex 4 possesses a hexanuclear structure where two trinuclear NiII₂MnII units are connected via a μ₁,₃-azido bridge. The temperature-dependent dc molar magnetic susceptibility measurements reveal that complexes 3 and 4 are antiferromagnetically coupled with the exchange coupling constants ( J) of -4.97, -0.14, -0.55 cm⁻¹ for 3 and -3.94 cm⁻¹ for 4. All complexes 2-4 show biomimetic catalytic oxidase activities. For catecholase like activity, the turnover numbers ( Kcat) are 768, 1985, and 2309 h⁻¹ for complexes 2-4, respectively, whereas for phenoxazinone synthase like activity, the turnover numbers are 3240, 3360, and 13 248 h⁻¹ for complexes 2-4, respectively. This difference in catalytic efficiencies is attributed to the variations in structures of the complexes and formation of active NiII-MnII species in solution during catalysis. The mass spectral analyses suggest the probable intermediate formation and cyclic voltammetry measurement suggest the reduction of Ni(II) to Ni(I) during catalytic reaction. The very high catalytic efficiencies for aerial dioxygen activation of all these heterometallic complexes as well as the highest activity of 4 is attributed to the coordinatively unsaturated penta-coordinated geometry or hexa-coordinated geometry with a solvent water molecule around Mn(II).
No takes yet. Share an insight, caveat, or question.
Mahapatra et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: